These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33363393)

  • 21. Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study.
    Leong DP; Loeb M; Mony PK; Rangarajan S; Mushtaha M; Miller MS; Dias M; Yegorov S; V M; Telci Caklili O; Temizhan A; Szuba A; Abat MEM; Mat-Nasir N; Diaz ML; Khansaheb H; Lopez-Jaramillo P; Duong M; Teo KK; Poirier P; Oliveira G; Avezum Á; Yusuf S
    Microbiol Spectr; 2024 Feb; 12(2):e0149223. PubMed ID: 38214526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
    Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
    Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.
    Stefan N; Birkenfeld AL; Schulze MB
    Nat Rev Endocrinol; 2021 Mar; 17(3):135-149. PubMed ID: 33479538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.
    Pasquarelli-do-Nascimento G; Braz-de-Melo HA; Faria SS; Santos IO; Kobinger GP; Magalhães KG
    Front Endocrinol (Lausanne); 2020; 11():530. PubMed ID: 32849309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020.
    Kim N; Aly A; Craver C; Garvey WT
    J Med Econ; 2023; 26(1):376-385. PubMed ID: 36812069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Possible mechanisms of impaired post-vaccination immune response in obesity].
    Dzhumagaziev AA; Kostinov MP; Bezrukova DA; Usaeva OV
    Vopr Pitan; 2021; 90(5):15-24. PubMed ID: 34719139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review.
    Richter FC; Alrubayyi A; Teijeira Crespo A; ; Hulin-Curtis S
    Oxf Open Immunol; 2021; 2(1):iqab001. PubMed ID: 34192269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycation-Driven Inflammation: COVID-19 Severity in Pregnant Women and Perinatal Outcomes.
    Di Martino D; Cappelletti M; Tondo M; Basello K; Garbin C; Speciani A; Ferrazzi E
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review.
    Pérez-Galarza J; Prócel C; Cañadas C; Aguirre D; Pibaque R; Bedón R; Sempértegui F; Drexhage H; Baldeón L
    Vaccines (Basel); 2021 Jan; 9(2):. PubMed ID: 33572702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
    Almerie MQ; Kerrigan DD
    Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing.
    Frasca D; Reidy L; Romero M; Diaz A; Cray C; Kahl K; Blomberg BB
    Int J Obes (Lond); 2022 Feb; 46(2):427-432. PubMed ID: 34744161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired immune response against SARS-CoV-2 infection is the major factor indirectly altering reproductive function in COVID-19 patients: a narrative review.
    Muyayalo KP; Gong GS; Kiyonga Aimeé K; Liao AH
    Hum Fertil (Camb); 2023 Oct; 26(4):778-796. PubMed ID: 37811836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 mRNA vaccine protects against SARS-CoV-2 Omicron BA.1 infection in diet-induced obese mice through boosting host innate antiviral responses.
    Chen Y; Song W; Li C; Wang J; Liu F; Ye Z; Ren P; Tong Y; Li J; Ou Z; Lee AC; Cai JP; Wong BH; Chan JF; Yuen KY; Zhang AJ; Chu H
    EBioMedicine; 2023 Mar; 89():104485. PubMed ID: 36857860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries.
    Epsi NJ; Richard SA; Laing ED; Fries AC; Millar E; Simons MP; English C; Colombo CJ; Colombo RE; Lindholm DA; Ganesan A; Maves RC; Huprikar N; Larson D; Mende K; Chi SW; Madar C; Lalani T; Broder CC; Tribble D; Agan BK; Burgess TH; Pollett SD;
    J Infect Dis; 2021 Nov; 224(9):1462-1472. PubMed ID: 34331541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes.
    Korakas E; Ikonomidis I; Kousathana F; Balampanis K; Kountouri A; Raptis A; Palaiodimou L; Kokkinos A; Lambadiari V
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E105-E109. PubMed ID: 32459524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
    Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
    Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
    El-Missiry MA; El-Missiry ZMA; Othman AI
    Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood.
    Muscogiuri G; Bettini S; Boschetti M; Barrea L; Savastano S; Colao A;
    Int J Obes (Lond); 2022 Jul; 46(7):1254-1261. PubMed ID: 35393519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19.
    Khwatenge CN; Pate M; Miller LC; Sang Y
    Front Immunol; 2021; 12():732913. PubMed ID: 34737743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19.
    Hosoya T; Oba S; Komiya Y; Kawata D; Kamiya M; Iwai H; Miyamoto S; Kataoka M; Tobiume M; Kanno T; Ainai A; Sato H; Hirakawa A; Mitsui Y; Satoh T; Wakabayashi K; Yamada T; Otomo Y; Miyazaki Y; Hasegawa H; Suzuki T; Yasuda S
    Proc Natl Acad Sci U S A; 2023 May; 120(22):e2300155120. PubMed ID: 37216518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.